eLabNext announced today that they’ve entered into a “preferred vendor” partnership with US Lab Partners, a strategic consulting and advisory firm.
In life science laboratories, where precision and purity are non-negotiable, the demand for environmentally friendly solutions is now higher than it has ever been. Laboratories are grappling with the environmental impact of their activities, and they are aware that the ever-increasing demand for plastic consumables is not resource-friendly. Therefore, in order to become more sustainable, future laboratory consumables made from plastic materials must be able to be manufactured from renewable or recycled raw materials.
NSG BioLabs, Singapore's largest provider of biotech co-working laboratory and office space, has announced a new partnership with Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, to support biotech startups by providing needed resources such as product and applications expertise and its networks to advance startup research and development (R&D).
The Eppendorf Innovation Company (EpIC) – a division of Eppendorf SE – continues to expand its international network. Through a targeted investment in Osage University Partners (OUP), EpIC will learn about investment opportunities in some of the most cutting-edge startups transitioning their academic discoveries into the commercial world through OUP’s network of university spinouts.
If information on devices, about people and running processes is disjointed and spread across numerous data silos, managers need a lot of time to find specific data. An IoT platform can consolidate this information into one system using a standardized application, and thus significantly reduce the time required to look up specific data. With Commercial IoT platforms, companies can therefore network, monitor, analyze and use data in new ways.
The globally active Eppendorf Group continues its growth track in Asia in a targeted manner and has opened a new site in Singapore. The new subsidiary is located in the heart of Singapore’s modern Biopolis science center and offers attractive office workplaces for sales and service activities, a modern pipette calibration laboratory and a demo laboratory. Here high-quality laboratory services, which include extensive customer training and maintenance offerings, are provided.
The internationally active life science company Eppendorf, headquartered in Hamburg, Germany, has completed its conversion to the European legal form Societas Europaea (SE) as of October 19, 2021. The company will operate as Eppendorf SE with immediate effect
In 2021, Eppendorf AG, the Hamburg life sciences company, is presenting its highly prestigious research prize for the 26th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn announced Dr. Tanmay Bharat, Sir William Dunn School of Pathology, University of Oxford, United Kingdom as the winner of the Eppendorf Award for European Investigators 2021.
FRAMINGHAM, Mass., Oct. 5, 2020 /PRNewswire/ -- Eppendorf, a leading life science company, announces that its Americas Market Region Commercial headquarters officially moved from Hauppauge, NY to Framingham, MA. Eppendorf develops and sells instruments, consumables and services for liquid-, sample-, and cell handling to laboratories. The strategic move is to support continued growth by being in closer proximity to world renowned academic institutions and research centers, top pharmaceutical and biotechnology companies, and premier hospitals and clinical laboratories.
The globally active Eppendorf Group was once again able to increase its consolidated revenue in the first half of 2020. Despite the global restrictions necessitated by the coronavirus pandemic, revenue grew by 6.6% to €403.7 million (prior-year: €378.5 million). Operating profit (EBIT) in the first half of the year remained at around the same high level of 2019, amounting to €65.5 million against €66.7 million in the previous year. This was as expected given the extensive and ongoing investment in growth and technology at the Group’s global locations. The EBIT margin amounts to 16.2% (prior year: 17.6%).